NewAmsterdam Pharma Company N.V.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $864.6M
Liabilities Breakdown FY2024
Total Liabilities: $107.1M
Asset Breakdown
Total Assets: $864.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $771.7M | 89.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $242.0K | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $92.6M | 10.7% |
Liabilities Breakdown
Total Liabilities: $107.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.7M | 4.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $102.4M | 95.6% |